Session » Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Safety II
-
Abstract Number: 1694
Infection Risk in Patients with Low Immunoglobulins Following Rituximab Treatment in Rheumatoid Arthritis
-
Abstract Number: 1696
Quantitative Evaluation of Dermal Atrophy by High-Resolution Ultrasonography, Comparing Between Patients Under Long-Term Treatment with Prednisolone or Methylprednisolone
-
Abstract Number: 1697
Meta-Analysis of Malignancies, Serious Infections, and Serious Adverse Events with Tofacitinib or Biologic Treatment in Rheumatoid Arthritis Clinical Trials